These analyses can quantify the expression and structure of ACE2 and other possible markers, such as TMPRS2 [23,24], through all oral, head and neck areas of an entire population, and thus a liquid-based cytology evaluation of oral tissue may provide a novel preventive medical avenue against COVID-19. This evidence concerns the gene ACE2 and COVID-19.